| Year |
Citation |
Score |
| 2024 |
Wilson E, Umans J, Swarovski M, Minhas P, Midttun Ø, Ulvik AA, Shahid-Besanti M, Linortner P, Mhatre S, Wang Q, Channappa D, Corso N, Tian L, Fredericks C, Kerchner G, ... ... Zabetian C, et al. Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction. Research Square. PMID 39399688 DOI: 10.21203/rs.3.rs-4980210/v1 |
0.415 |
|
| 2024 |
Lorenzo-Betancor O, Mehta S, Ramchandra J, Mumuney S, Schumacher-Schuh AF, Cornejo-Olivas M, Sarapura-Castro EH, Torres L, Inca-Martinez MA, Mazzetti P, Cosentino C, Micheli F, Tumas V, Dieguez E, Raggio V, ... ... Zabetian CP, et al. Parkinson's Disease Gene Screening in Familial Cases from Central and South America. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 39051491 DOI: 10.1002/mds.29931 |
0.453 |
|
| 2024 |
Young CB, Cholerton B, Smith AM, Shahid-Besanti M, Abdelnour C, Mormino EC, Hu SC, Chung KA, Peterson A, Rosenthal L, Pantelyat A, Dawson TM, Quinn J, Zabetian CP, Montine TJ, et al. The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials. Neurology. 103: e209609. PMID 38870440 DOI: 10.1212/WNL.0000000000209609 |
0.408 |
|
| 2023 |
Leal TP, Rao SC, French-Kwawu JN, Gouveia MH, Borda V, Bandres-Ciga S, Inca-Martinez M, Mason EA, Horimoto ARVR, Loesch DP, Sarihan EI, Cornejo-Olivas MR, Torres LE, Mazzetti-Soler PE, Cosentino C, ... ... Zabetian CP, et al. X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37469269 DOI: 10.1002/mds.29508 |
0.439 |
|
| 2023 |
Morris R, Martini DN, Kelly VE, Smulders K, Ramsey K, Hiller A, Chung KA, Hu SC, Zabetian CP, Poston KL, Mata IF, Edwards KL, Lapidus J, Cholerton B, Montine TJ, et al. Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson's disease. Clinical Parkinsonism & Related Disorders. 9: 100201. PMID 37252677 DOI: 10.1016/j.prdoa.2023.100201 |
0.416 |
|
| 2023 |
Amin RM, Phillips JJ, Humbert AT, Cholerton BA, Short VD, Smith MJ, Zabetian CP, Mata IF, Kelly VE. Associations between baseline cognitive status and motor outcomes after treadmill training in people with Parkinson's disease: a pilot study. Disability and Rehabilitation. 1-10. PMID 37010072 DOI: 10.1080/09638288.2023.2189318 |
0.344 |
|
| 2023 |
Leal TP, French-Kwawu JN, Gouveia MH, Borda V, Inca-Martinez M, Mason EA, Horimoto AR, Loesch DP, Sarihan EI, Cornejo-Olivas MR, Torres LE, Mazzetti-Soler PE, Cosentino C, Sarapura-Castro EH, Rivera-Valdivia A, ... ... Zabetian C, et al. X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson Disease. Medrxiv : the Preprint Server For Health Sciences. PMID 36778409 DOI: 10.1101/2023.01.31.23285199 |
0.414 |
|
| 2022 |
Lorenzo-Betancor O, Galosi L, Bonfili L, Eleuteri AM, Cecarini V, Verin R, Dini F, Attili AR, Berardi S, Biagini L, Robino P, Stella MC, Yearout D, Dorschner MO, Tsuang DW, ... ... Zabetian CP, et al. Homozygous CADPS2 Mutations Cause Neurodegenerative Disease with Lewy Body-like Pathology in Parrots. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36086934 DOI: 10.1002/mds.29211 |
0.488 |
|
| 2022 |
Loesch DP, Horimoto ARVR, Sarihan EI, Inca-Martinez M, Mason E, Cornejo-Olivas M, Torres L, Mazzetti P, Cosentino C, Sarapura-Castro E, Rivera-Valdivia A, Medina AC, Dieguez E, Raggio V, Lescano A, ... ... Zabetian CP, et al. Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson's disease cohort. Parkinsonism & Related Disorders. 102: 7-15. PMID 35917738 DOI: 10.1016/j.parkreldis.2022.06.010 |
0.444 |
|
| 2022 |
Morris R, Martini DN, Ramsey K, Kelly VE, Smulders K, Hiller A, Chung KA, Hu SC, Zabetian CP, Poston KL, Mata IF, Edwards KL, Lapidus J, Cholerton B, Montine TJ, et al. Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's disease. Npj Parkinson's Disease. 8: 78. PMID 35725575 DOI: 10.1038/s41531-022-00344-5 |
0.378 |
|
| 2022 |
Hwangbo N, Zhang X, Raftery D, Gu H, Hu SC, Montine TJ, Quinn JF, Chung KA, Hiller AL, Wang D, Fei Q, Bettcher L, Zabetian CP, Peskind ER, Li G, et al. Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid. Metabolites. 12. PMID 35448464 DOI: 10.3390/metabo12040277 |
0.42 |
|
| 2021 |
Wallen ZD, Stone WJ, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Exploring human-genome gut-microbiome interaction in Parkinson's disease. Npj Parkinson's Disease. 7: 74. PMID 34408160 DOI: 10.1038/s41531-021-00218-2 |
0.452 |
|
| 2021 |
Cholerton BA, Poston KL, Yang L, Rosenthal LS, Dawson TM, Pantelyat A, Edwards KL, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Montine TJ, Zabetian CP. Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 1-12. PMID 34355669 DOI: 10.1080/13803395.2021.1927995 |
0.393 |
|
| 2021 |
Loesch DP, Horimoto ARVR, Heilbron K, Sarihan EI, Inca-Martinez M, Mason E, Cornejo-Olivas M, Torres L, Mazzetti P, Cosentino C, Sarapura-Castro E, Rivera-Valdivia A, Medina AC, Dieguez E, Raggio V, ... ... Zabetian CP, et al. Characterizing the Genetic Architecture of Parkinson's Disease in Latinos. Annals of Neurology. PMID 34227697 DOI: 10.1002/ana.26153 |
0.469 |
|
| 2021 |
Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, Sheng L, Borden K, Khrisat T, Pan C, Zabetian CP, Peskind ER, Quinn JF, Montine TJ, Aasly J, et al. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles. Neurology. 96: e2332-e2345. PMID 34032594 DOI: 10.1212/WNL.0000000000011853 |
0.341 |
|
| 2021 |
Lai D, Alipanahi B, Fontanillas P, Schwantes-An TH, Aasly J, Alcalay RN, Beecham GW, Berg D, Bressman S, Brice A, Brockman K, Clark L, Cookson M, Das S, Van Deerlin V, ... ... Zabetian CP, et al. Genome-wide association studies of LRRK2 modifiers of Parkinson's disease. Annals of Neurology. PMID 33938021 DOI: 10.1002/ana.26094 |
0.377 |
|
| 2020 |
Palmer WC, Cholerton BA, Zabetian CP, Montine TJ, Grabowski TJ, Rane S. Resting-State Cerebello-Cortical Dysfunction in Parkinson's Disease. Frontiers in Neurology. 11: 594213. PMID 33584497 DOI: 10.3389/fneur.2020.594213 |
0.397 |
|
| 2020 |
Martini DN, Morris R, Madhyastha TM, Grabowski TJ, Oakley J, Hu SC, Zabetian CP, Edwards KL, Hiller A, Chung K, Ramsey K, Lapidus JA, Cholerton B, Montine TJ, Quinn JF, et al. Relationship between Sensorimotor Inhibition and Mobility in Older Adults with and without Parkinson's Disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 33252618 DOI: 10.1093/gerona/glaa300 |
0.343 |
|
| 2020 |
Sarihan EI, Pérez-Palma E, Niestroj LM, Loesch D, Inca-Martinez M, Horimoto ARVR, Cornejo-Olivas M, Torres L, Mazzetti P, Cosentino C, Sarapura-Castro E, Rivera-Valdivia A, Dieguez E, Raggio V, Lescano A, ... ... Zabetian CP, et al. Genome-Wide Analysis of Copy Number Variation in Latin American Parkinson's Disease Patients. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33150996 DOI: 10.1002/mds.28353 |
0.348 |
|
| 2020 |
Martini DN, Morris R, Kelly VE, Hiller A, Chung KA, Hu SC, Zabetian CP, Oakley J, Poston K, Mata IF, Edwards KL, Lapidus JA, Grabowski TJ, Montine TJ, Quinn JF, et al. Sensorimotor Inhibition and Mobility in Genetic Subgroups of Parkinson's Disease. Frontiers in Neurology. 11: 893. PMID 33013627 DOI: 10.3389/Fneur.2020.00893 |
0.504 |
|
| 2020 |
Rane S, Owen J, Hippe DS, Cholerton B, Zabetian CP, Montine T, Grabowski TJ. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32937003 DOI: 10.1111/Jon.12778 |
0.357 |
|
| 2020 |
Phongpreecha T, Cholerton B, Mata IF, Zabetian CP, Poston KL, Aghaeepour N, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Edwards KL, Montine TJ. Multivariate prediction of dementia in Parkinson's disease. Npj Parkinson's Disease. 6: 20. PMID 32885039 DOI: 10.1038/S41531-020-00121-2 |
0.456 |
|
| 2020 |
Gryc W, Roberts KA, Zabetian CP, Weintraub D, Trojanowski JQ, Quinn JF, Hiller AL, Chung KA, Poston KL, Yang L, Hu SC, Edwards KL, Montine TJ, Cholerton BA. Hallucinations and Development of Dementia in Parkinson's Disease. Journal of Parkinson's Disease. PMID 32741842 DOI: 10.3233/Jpd-202116 |
0.535 |
|
| 2020 |
Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P, Khrisat T, Xie Z, Li N, Liu Z, Tian C, Bercow M, Matsumoto J, Zabetian CP, Peskind E, et al. Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis. Acta Neuropathologica Communications. 8: 102. PMID 32641150 DOI: 10.1186/S40478-020-00983-W |
0.397 |
|
| 2020 |
Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Parkinson's Disease. 6: 11. PMID 32566740 DOI: 10.1038/S41531-020-0112-6 |
0.502 |
|
| 2020 |
Rane S, Koh N, Oakley J, Caso C, Zabetian CP, Cholerton B, Montine TJ, Grabowski T. Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease. Parkinsonism & Related Disorders. 76: 21-28. PMID 32559629 DOI: 10.1016/J.Parkreldis.2020.05.014 |
0.388 |
|
| 2020 |
Santos-Lobato BL, Schumacher-Schuh AF, Rieder CRM, Hutz MH, Borges V, Ferraz HB, Mata IF, Zabetian CP, Tumas V. Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease. Arquivos De Neuro-Psiquiatria. PMID 32294749 DOI: 10.1590/0004-282X20190191 |
0.537 |
|
| 2020 |
Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, et al. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau. Brain : a Journal of Neurology. PMID 32065223 DOI: 10.1093/Brain/Awaa021 |
0.478 |
|
| 2020 |
Cholerton B, Poston KL, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Specketer K, Montine TJ, Edwards KL, Zabetian CP. Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease. Movement Disorders Clinical Practice. 7: 61-69. PMID 31970213 DOI: 10.1002/Mdc3.12870 |
0.481 |
|
| 2019 |
Kim HM, Nazor C, Zabetian CP, Quinn JF, Chung KA, Hiller AL, Hu SC, Leverenz JB, Montine TJ, Edwards KL, Cholerton B. Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures. Clinical Parkinsonism & Related Disorders. 1: 91-97. PMID 32368733 DOI: 10.1016/j.prdoa.2019.08.006 |
0.393 |
|
| 2019 |
Morris R, Martini DN, Smulders K, Kelly VE, Zabetian CP, Poston K, Hiller A, Chung KA, Yang L, Hu SC, Edwards KL, Cholerton B, Grabowski TJ, Montine TJ, Quinn JF, et al. Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease. Parkinsonism & Related Disorders. 69: 104-110. PMID 31731260 DOI: 10.1016/J.Parkreldis.2019.06.014 |
0.511 |
|
| 2019 |
Specketer K, Zabetian CP, Edwards KL, Tian L, Quinn JF, Peterson-Hiller AL, Chung KA, Hu SC, Montine TJ, Cholerton BA. Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 31177941 DOI: 10.1080/13803395.2019.1623180 |
0.467 |
|
| 2019 |
Day TKM, Madhyastha TM, Lee A, Zabetian CP, Montine TJ, Grabowski T. Effect of dopaminergic medications on BOLD variability and functional connectivity in Parkinson's disease. Brain Connectivity. PMID 31131605 DOI: 10.1089/Brain.2019.0677 |
0.496 |
|
| 2019 |
Stewart T, Shi M, Mehrotra A, Aro P, Soltys D, Kerr KF, Zabetian CP, Peskind ER, Taylor P, Shaw LM, Trojanowski JQ, Zhang J. Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 30958379 DOI: 10.3233/Jad-190069 |
0.375 |
|
| 2019 |
Hendershott TR, Zhu D, Llanes S, Zabetian CP, Quinn J, Edwards KL, Leverenz JB, Montine T, Cholerton B, Poston KL. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 285-291. PMID 30776152 DOI: 10.1002/Mds.27575 |
0.439 |
|
| 2019 |
Velez-Pardo C, Lorenzo-Betancor O, Jimenez-Del-Rio M, Moreno S, Lopera F, Cornejo-Olivas M, Torres L, Inca-Martinez M, Mazzetti P, Cosentino C, Yearout D, Waldherr SM, Zabetian CP, Mata IF. The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru. Parkinsonism & Related Disorders. PMID 30765263 DOI: 10.1016/J.Parkreldis.2019.01.030 |
0.552 |
|
| 2019 |
Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, ... ... Zabetian CP, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337. PMID 30745444 DOI: 10.1212/Wnl.0000000000006926 |
0.445 |
|
| 2018 |
Kim HM, Leverenz JB, Burdick DJ, Srivatsal S, Pate J, Hu SC, Millard SP, Davis MY, Samii A, Zabetian CP. Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry. Parkinson's Disease. 2018: 3719578. PMID 30515290 DOI: 10.1155/2018/3719578 |
0.495 |
|
| 2018 |
Wallen ZD, Chen H, Hill-Burns EM, Factor SA, Zabetian CP, Payami H. Plasticity-related gene 3 () and age at diagnosis of Parkinson disease. Neurology. Genetics. 4: e271. PMID 30338293 DOI: 10.1212/Nxg.0000000000000271 |
0.511 |
|
| 2018 |
Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, et al. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30216541 DOI: 10.1002/Mds.110 |
0.437 |
|
| 2018 |
Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool immune profiles evince gastrointestinal inflammation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29572994 DOI: 10.1002/Mds.27326 |
0.419 |
|
| 2018 |
Cholerton B, Johnson CO, Fish B, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Hu SC, Mata IF, Leverenz JB, Poston KL, Montine TJ, Zabetian CP, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & Related Disorders. PMID 29478836 DOI: 10.1016/J.Parkreldis.2018.02.007 |
0.438 |
|
| 2018 |
Liu SY, Wile DJ, Fu JF, Valerio J, Shahinfard E, McCormick S, Mabrouk R, Vafai N, McKenzie J, Neilson N, Perez-Soriano A, Arena JE, Cherkasova M, Chan P, Zhang J, ... Zabetian CP, et al. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study. The Lancet. Neurology. PMID 29456161 DOI: 10.1016/S1474-4422(18)30032-2 |
0.479 |
|
| 2018 |
Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, ... ... Zabetian CP, et al. Erratum: Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry. Npj Parkinson's Disease. 4: 3. PMID 29367946 DOI: 10.1038/s41531-017-0025-1 |
0.403 |
|
| 2017 |
Licking N, Murchison C, Cholerton B, Zabetian CP, Hu SC, Montine TJ, Peterson-Hiller AL, Chung KA, Edwards K, Leverenz JB, Quinn JF. Homocysteine and cognitive function in Parkinson's disease. Parkinsonism & Related Disorders. PMID 28807493 DOI: 10.1016/J.Parkreldis.2017.08.005 |
0.471 |
|
| 2017 |
Zabetian CP, Mata IF. LARGE-PD: Examining the genetics of Parkinson's disease in Latin America. Movement Disorders. 32: 1330-1331. PMID 28657124 DOI: 10.1002/Mds.27081 |
0.552 |
|
| 2017 |
Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, ... ... Zabetian CP, et al. Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry. Npj Parkinson's Disease. 3: 19. PMID 28649619 DOI: 10.1038/S41531-017-0020-6 |
0.497 |
|
| 2017 |
Santos-Lobato BL, Borges V, Ferraz HB, Mata IF, Zabetian CP, Tumas V. Association of a neuronal nitric oxide synthase gene polymorphism with levodopa-induced dyskinesia in Parkinson's disease. Nitric Oxide : Biology and Chemistry. PMID 28602747 DOI: 10.1016/J.Niox.2017.06.004 |
0.507 |
|
| 2017 |
Mata IF, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Espay AJ, Revilla FJ, ... ... Zabetian CP, et al. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease. Neurobiology of Aging. PMID 28526295 DOI: 10.1016/J.Neurobiolaging.2017.04.009 |
0.49 |
|
| 2017 |
Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, Vafai N, Hasegawa K, Zhang J, McKenzie J, Neilson N, Strongosky A, Uitti RJ, Guttman M, Zabetian CP, et al. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. The Lancet. Neurology. PMID 28336296 DOI: 10.1016/S1474-4422(17)30056-X |
0.425 |
|
| 2017 |
Yang L, Stewart T, Shi M, Pottiez G, Dator R, Wu R, Aro P, Schuster RJ, Ginghina C, Pan C, Gao Y, Qian W, Zabetian CP, Hu SC, Quinn JF, et al. An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression. Proteomics. Clinical Applications. PMID 28319654 DOI: 10.1002/Prca.201700045 |
0.436 |
|
| 2017 |
Gatto EM, Allegri RF, Da Prat G, Chrem Mendez P, Hanna DS, Dorschner MO, Surace EI, Zabetian CP, Mata IF. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America. Neurobiology of Aging. PMID 28268100 DOI: 10.1016/J.Neurobiolaging.2017.02.002 |
0.384 |
|
| 2017 |
Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28195358 DOI: 10.1002/Mds.26942 |
0.548 |
|
| 2017 |
Cooper CA, Jain N, Gallagher MD, Weintraub D, Xie SX, Berlyand Y, Espay AJ, Quinn J, Edwards KL, Montine T, Van Deerlin VM, Trojanowski J, Zabetian CP, Chen-Plotkin AS. Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Annals of Clinical and Translational Neurology. 4: 15-25. PMID 28078311 DOI: 10.1002/Acn3.371 |
0.539 |
|
| 2017 |
Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, ... ... Zabetian CP, et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. The Lancet. Neurology. 16: 55-65. PMID 27979356 DOI: 10.1016/S1474-4422(16)30291-5 |
0.306 |
|
| 2017 |
Mata IF, Davis MY, Lopez AN, Dorschner MO, Martinez E, Yearout D, Cholerton BA, Hu SC, Edwards KL, Bird TD, Zabetian CP. The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 174: 113. PMID 27943640 DOI: 10.1002/Ajmg.B.32510 |
0.392 |
|
| 2016 |
Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, ... ... Zabetian CP, et al. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. Jama Neurology. PMID 27571329 DOI: 10.1001/Jamaneurol.2016.2245 |
0.541 |
|
| 2016 |
Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, ... ... Zabetian CP, et al. Arguing against the proposed definition changes of PD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27492190 DOI: 10.1002/Mds.26721 |
0.524 |
|
| 2016 |
Hill-Burns EM, Ross OA, Wissemann WT, Soto-Ortolaza AI, Zareparsi S, Siuda J, Lynch T, Wszolek ZK, Silburn PA, Mellick GD, Ritz B, Scherzer CR, Zabetian CP, Factor SA, Breheny PJ, et al. Identification of genetic modifiers of age-at-onset for familial Parkinson's disease. Human Molecular Genetics. PMID 27402877 DOI: 10.1093/Hmg/Ddw206 |
0.502 |
|
| 2016 |
Costa-Mallen P, Zabetian CP, Hu SC, Agarwal P, Yearout D, Checkoway H. Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 27349967 DOI: 10.1007/S00702-016-1590-X |
0.452 |
|
| 2016 |
Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, et al. CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27234211 DOI: 10.1016/J.Jalz.2016.04.003 |
0.47 |
|
| 2016 |
Wang L, Maldonado L, Beecham GW, Martin ER, Evatt ML, Ritchie JC, Haines JL, Zabetian CP, Payami H, Pericak-Vance MA, Vance JM, Scott WK. DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient. Neurology. Genetics. 2: e72. PMID 27123490 DOI: 10.1212/Nxg.0000000000000072 |
0.422 |
|
| 2016 |
Mata IF, Davis MY, Lopez AN, Dorschner MO, Martinez E, Yearout D, Cholerton BA, Hu SC, Edwards KL, Bird TD, Zabetian CP. The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27111571 DOI: 10.1002/Ajmg.B.32452 |
0.498 |
|
| 2016 |
Costa-Mallen P, Zabetian CP, Agarwal P, Hu SC, Yearout D, Samii A, Leverenz JB, Roberts JW, Checkoway H. Response to the letter "Haptoglobin phenotype and Parkinson disease risk" by Delanghe et al. Parkinsonism & Related Disorders. 22: 110-1. PMID 26708126 DOI: 10.1016/J.Parkreldis.2015.10.021 |
0.341 |
|
| 2015 |
Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, Flanagan M, Crane PK, Grabowski TJ, Montine KS, Montine TJ. Precision Medicine: Clarity for the Complexity of Dementia. The American Journal of Pathology. PMID 26724389 DOI: 10.1016/J.Ajpath.2015.12.001 |
0.401 |
|
| 2015 |
Zabetian CP. Review of Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, 5th ed. Jama Neurology. 72: 1538. PMID 26658980 DOI: 10.1001/Jamaneurol.2015.2634 |
0.315 |
|
| 2015 |
Sobreira E, Pena-Pereira MA, Eckeli AL, Sobreira-Neto MA, Chagas MH, Foss MP, Cholerton B, Zabetian CP, Mata IF, Tumas V. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised. Arquivos De Neuro-Psiquiatria. 73: 929-33. PMID 26517216 DOI: 10.1590/0004-282X20150156 |
0.308 |
|
| 2015 |
Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, ... ... Zabetian CP, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/S13024-015-0045-4 |
0.514 |
|
| 2015 |
Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, ... ... Zabetian CP, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/Mds.26359 |
0.516 |
|
| 2015 |
Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heutink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, ... ... Zabetian C, et al. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study. The Lancet. Neurology. 14: 1002-9. PMID 26271532 DOI: 10.1016/S1474-4422(15)00178-7 |
0.435 |
|
| 2015 |
Costa-Mallen P, Zabetian CP, Agarwal P, Hu SC, Yearout D, Samii A, Leverenz JB, Roberts JW, Checkoway H. Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk. Parkinsonism & Related Disorders. 21: 1087-92. PMID 26228081 DOI: 10.1016/J.Parkreldis.2015.07.006 |
0.488 |
|
| 2015 |
Perandones C, Pellene LA, Giugni JC, Calvo DS, Raina GB, Cuevas SM, Mata IF, Zabetian CP, Caputo M, Corach D, Micheli FE, Radrizzani M. Letter to the Editor: Hypothesis: Somatic Mosaicism and Parkinson Disease. Experimental Neurobiology. 24: 173-5. PMID 26113797 DOI: 10.5607/En.2015.24.2.173 |
0.512 |
|
| 2015 |
Kelly VE, Johnson CO, McGough EL, Shumway-Cook A, Horak FB, Chung KA, Espay AJ, Revilla FJ, Devoto J, Wood-Siverio C, Factor SA, Cholerton B, Edwards KL, Peterson AL, Quinn JF, ... ... Zabetian CP, et al. Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease. Parkinsonism & Related Disorders. 21: 692-7. PMID 25943529 DOI: 10.1016/J.Parkreldis.2015.04.002 |
0.455 |
|
| 2015 |
Cornejo-Olivas MR, Torres L, Mata IF, Mazzetti P, Rivas D, Cosentino C, Inca-Martinez M, Cuba JM, Zabetian CP, Leverenz JB. A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics. Parkinsonism & Related Disorders. 21: 444-8. PMID 25817512 DOI: 10.1016/J.Parkreldis.2015.01.005 |
0.469 |
|
| 2015 |
Bekris LM, Tsuang DW, Peskind ER, Yu CE, Montine TJ, Zhang J, Zabetian CP, Leverenz JB. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 936-44. PMID 25808939 DOI: 10.1002/Mds.26172 |
0.47 |
|
| 2015 |
Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Zabetian CP, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/Mds.26161 |
0.567 |
|
| 2015 |
Stewart T, Sossi V, Aasly JO, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Wang Y, Ginghina C, Liu C, Cain KC, Auinger P, et al. Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity. Acta Neuropathologica Communications. 3: 7. PMID 25637461 DOI: 10.1186/S40478-015-0185-3 |
0.534 |
|
| 2015 |
Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. Molecular & Cellular Proteomics : McP. 14: 544-55. PMID 25556233 DOI: 10.1074/Mcp.M114.040576 |
0.507 |
|
| 2015 |
Swanson CR, Li K, Unger TL, Gallagher MD, Van Deerlin VM, Agarwal P, Leverenz J, Roberts J, Samii A, Gross RG, Hurtig H, Rick J, Weintraub D, Trojanowski JQ, Zabetian C, et al. Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 805-12. PMID 25227208 DOI: 10.1002/Mds.26022 |
0.528 |
|
| 2014 |
Hamza TH, Hill-Burns EM, Scott WK, Vance JM, Factor SA, Zabetian CP, Payami H. Glutamate receptor gene GRIN2A, coffee, and Parkinson disease. Plos Genetics. 10: e1004774. PMID 25411979 DOI: 10.1371/Journal.Pgen.1004774 |
0.368 |
|
| 2014 |
Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, ... ... Zabetian CP, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. Jama Neurology. 71: 1405-12. PMID 25178429 DOI: 10.1001/Jamaneurol.2014.1455 |
0.489 |
|
| 2014 |
Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, ... ... Zabetian CP, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1258-64. PMID 25073717 DOI: 10.1002/Mds.25924 |
0.456 |
|
| 2014 |
Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathologica. 128: 639-50. PMID 24997849 DOI: 10.1007/S00401-014-1314-Y |
0.427 |
|
| 2014 |
Hatano T, Funayama M, Kubo S, Mata IF, Oji Y, Mori A, Zabetian CP, Waldherr SM, Yoshino H, Oyama G, Shimo Y, Fujimoto K, Oshima H, Kunii Y, Yabe H, et al. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease. Neurobiology of Aging. 35: 2656.e17-23. PMID 24973808 DOI: 10.1016/J.Neurobiolaging.2014.05.025 |
0.511 |
|
| 2014 |
Pan C, Zhou Y, Dator R, Ginghina C, Zhao Y, Movius J, Peskind E, Zabetian CP, Quinn J, Galasko D, Stewart T, Shi M, Zhang J. Targeted discovery and validation of plasma biomarkers of Parkinson's disease. Journal of Proteome Research. 13: 4535-45. PMID 24853996 DOI: 10.1021/Pr500421V |
0.501 |
|
| 2014 |
Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL. Evaluation of mild cognitive impairment subtypes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 756-64. PMID 24710804 DOI: 10.1002/Mds.25875 |
0.501 |
|
| 2014 |
Perandones C, Giugni JC, Calvo DS, Raina GB, De Jorge Lopez L, Volpini V, Zabetian CP, Mata IF, Caputo M, Corach D, Radrizzani M, Micheli FE. Mosaicism of alpha-synuclein gene rearrangements: report of two unrelated cases of early-onset parkinsonism. Parkinsonism & Related Disorders. 20: 558-61. PMID 24552873 DOI: 10.1016/J.Parkreldis.2013.11.014 |
0.338 |
|
| 2014 |
Hill-Burns EM, Wissemann WT, Hamza TH, Factor SA, Zabetian CP, Payami H. Identification of a novel Parkinson's disease locus via stratified genome-wide association study. Bmc Genomics. 15: 118. PMID 24511991 DOI: 10.1186/1471-2164-15-118 |
0.55 |
|
| 2014 |
Wan JY, Edwards KL, Hutter CM, Mata IF, Samii A, Roberts JW, Agarwal P, Checkoway H, Farin FM, Yearout D, Zabetian CP. Association mapping of the PARK10 region for Parkinson's disease susceptibility genes. Parkinsonism & Related Disorders. 20: 93-8. PMID 24156912 DOI: 10.1016/J.Parkreldis.2013.10.001 |
0.525 |
|
| 2014 |
Stewart T, Sui YT, Gonzalez-Cuyar LF, Wong DT, Akin DM, Tumas V, Aasly J, Ashmore E, Aro P, Ginghina C, Korff A, Zabetian CP, Leverenz JB, Shi M, Zhang J. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control. Neurobiology of Aging. 35: 418-20. PMID 24041968 DOI: 10.1016/J.Neurobiolaging.2013.08.008 |
0.517 |
|
| 2013 |
Wissemann WT, Hill-Burns EM, Zabetian CP, Factor SA, Patsopoulos N, Hoglund B, Holcomb C, Donahue RJ, Thomson G, Erlich H, Payami H. Association of Parkinson disease with structural and regulatory variants in the HLA region. American Journal of Human Genetics. 93: 984-93. PMID 24183452 DOI: 10.1016/J.Ajhg.2013.10.009 |
0.42 |
|
| 2013 |
Cholerton BA, Zabetian CP, Quinn JF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Edwards KL, Montine TJ, Leverenz JB. Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. Journal of Parkinson's Disease. 3: 205-14. PMID 23938350 DOI: 10.3233/Jpd-130189 |
0.481 |
|
| 2013 |
Chahine LM, Qiang J, Ashbridge E, Minger J, Yearout D, Horn S, Colcher A, Hurtig HI, Lee VM, Van Deerlin VM, Leverenz JB, Siderowf AD, Trojanowski JQ, Zabetian CP, Chen-Plotkin A. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. Jama Neurology. 70: 852-8. PMID 23699752 DOI: 10.1001/Jamaneurol.2013.1274 |
0.546 |
|
| 2013 |
Korvatska O, Strand NS, Berndt JD, Strovas T, Chen DH, Leverenz JB, Kiianitsa K, Mata IF, Karakoc E, Greenup JL, Bonkowski E, Chuang J, Moon RT, Eichler EE, Nickerson DA, ... Zabetian CP, et al. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). Human Molecular Genetics. 22: 3259-68. PMID 23595882 DOI: 10.1093/Hmg/Ddt180 |
0.429 |
|
| 2013 |
Dombroski BA, Galasko DR, Mata IF, Zabetian CP, Craig UK, Garruto RM, Oyanagi K, Schellenberg GD. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. Jama Neurology. 70: 742-5. PMID 23588498 DOI: 10.1001/Jamaneurol.2013.1817 |
0.323 |
|
| 2013 |
Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Annals of Neurology. 74: 119-27. PMID 23447138 DOI: 10.1002/Ana.23872 |
0.52 |
|
| 2013 |
Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, ... ... Zabetian CP, et al. APOE ε4 increases risk for dementia in pure synucleinopathies. Jama Neurology. 70: 223-8. PMID 23407718 DOI: 10.1001/Jamaneurol.2013.600 |
0.32 |
|
| 2013 |
Mata IF, Alvarez V, Ribacoba R, Infante J, Sierra M, Gómez-Garre P, Mir P, Waldherr S, Yearout D, Zabetian CP. Novel Lrrk2-p.S1761R mutation is not a common cause of Parkinson's disease in Spain. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 248. PMID 23389884 DOI: 10.1002/Mds.25293 |
0.5 |
|
| 2013 |
Hall TO, Wan JY, Mata IF, Kerr KF, Snapinn KW, Samii A, Roberts JW, Agarwal P, Zabetian CP, Edwards KL. Risk prediction for complex diseases: application to Parkinson disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 15: 361-7. PMID 23222663 DOI: 10.1038/Gim.2012.109 |
0.453 |
|
| 2013 |
Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB. Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 609-14. PMID 23164549 DOI: 10.1016/J.Jalz.2012.07.006 |
0.458 |
|
| 2013 |
Hill-Burns EM, Singh N, Ganguly P, Hamza TH, Montimurro J, Kay DM, Yearout D, Sheehan P, Frodey K, McLear JA, Feany MB, Hanes SD, Wolfgang WJ, Zabetian CP, Factor SA, et al. A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. The Pharmacogenomics Journal. 13: 530-7. PMID 23032990 DOI: 10.1038/Tpj.2012.38 |
0.465 |
|
| 2012 |
Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/Srep00954 |
0.488 |
|
| 2012 |
Mata IF, Checkoway H, Hutter CM, Samii A, Roberts JW, Kim HM, Agarwal P, Alvarez V, Ribacoba R, Pastor P, Lorenzo-Betancor O, Infante J, Sierra M, Gómez-Garre P, Mir P, ... ... Zabetian CP, et al. Common variation in the LRRK2 gene is a risk factor for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1822-5. PMID 23115130 DOI: 10.1002/Mds.25226 |
0.526 |
|
| 2012 |
Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, ... ... Zabetian CP, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 79: 1944-50. PMID 23035075 DOI: 10.1212/Wnl.0B013E3182735E9A |
0.448 |
|
| 2012 |
Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, ... ... Zabetian CP, et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Annals of Neurology. 71: 370-84. PMID 22451204 DOI: 10.1002/Ana.22687 |
0.46 |
|
| 2012 |
Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, ... ... Zabetian CP, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. Plos Genetics. 8: e1002548. PMID 22438815 DOI: 10.1371/Journal.Pgen.1002548 |
0.485 |
|
| 2012 |
Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, et al. Phosphorylated α-synuclein in Parkinson's disease. Science Translational Medicine. 4: 121ra20. PMID 22344688 DOI: 10.1126/Scitranslmed.3002566 |
0.542 |
|
| 2012 |
Aasly JO, Shi M, Sossi V, Stewart T, Johansen KK, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Kim HM, Leverenz JB, Ginghina C, Armaly J, Edwards KL, et al. Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers. Neurology. 78: 55-61. PMID 22170881 DOI: 10.1212/Wnl.0B013E31823Ed101 |
0.536 |
|
| 2012 |
Shi M, Furay AR, Sossi V, Aasly JO, Armaly J, Wang Y, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Zhang J. DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function. Neurobiology of Aging. 33: 836.e5-7. PMID 22019052 DOI: 10.1016/J.Neurobiolaging.2011.09.015 |
0.546 |
|
| 2012 |
Chahine L, Ashbridge E, Minger J, Yearout D, Qiang J, Siderowf A, Hurtig H, Zabetian C, Lee V, Van Deerlin V, Trojanowski J, Chen-Plotkin A. Clinical and Biochemical Differences between Parkinson's Disease Patients With and Without Mutations in the Glucocerebrosidase Gene (P06.072) Neurology. 78: P06.072-P06.072. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.072 |
0.451 |
|
| 2011 |
Hill-Burns EM, Factor SA, Zabetian CP, Thomson G, Payami H. Evidence for more than one Parkinson's disease-associated variant within the HLA region. Plos One. 6: e27109. PMID 22096524 DOI: 10.1371/Journal.Pone.0027109 |
0.38 |
|
| 2011 |
Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, Tenesa A, Kusel VI, Sheehan P, Eaaswarkhanth M, Yearout D, Samii A, Roberts JW, Agarwal P, Bordelon Y, ... ... Zabetian CP, et al. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. Plos Genetics. 7: e1002237. PMID 21876681 DOI: 10.1371/Journal.Pgen.1002237 |
0.46 |
|
| 2011 |
Hill-Burns EM, Hamza TH, Zabetian CP, Factor SA, Payami H. An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: e107-8; author reply. PMID 21834891 DOI: 10.1111/J.1468-1331.2011.03464.X |
0.469 |
|
| 2011 |
Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2190-5. PMID 21714002 DOI: 10.1002/Mds.23806 |
0.433 |
|
| 2011 |
Mata IF, Wilhoite GJ, Yearout D, Bacon JA, Cornejo-Olivas M, Mazzetti P, Marca V, Ortega O, Acosta O, Cosentino C, Torres L, Medina AC, Perez-Pastene C, DÃaz-Grez F, Vilariño-Güell C, ... ... Zabetian CP, et al. Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America. Parkinsonism & Related Disorders. 17: 629-31. PMID 21632271 DOI: 10.1016/J.Parkreldis.2011.05.003 |
0.471 |
|
| 2011 |
Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, et al. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American Journal of Pathology. 178: 1509-16. PMID 21435440 DOI: 10.1016/J.Ajpath.2011.01.006 |
0.55 |
|
| 2011 |
Mata IF, Yearout D, Alvarez V, Coto E, de Mena L, Ribacoba R, Lorenzo-Betancor O, Samaranch L, Pastor P, Cervantes S, Infante J, Garcia-Gorostiaga I, Sierra M, Combarros O, Snapinn KW, ... ... Zabetian CP, et al. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 819-23. PMID 21425343 DOI: 10.1002/Mds.23642 |
0.487 |
|
| 2011 |
Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Annals of Neurology. 69: 570-80. PMID 21400565 DOI: 10.1002/Ana.22311 |
0.553 |
|
| 2011 |
Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, Pan C, Goodlett DR, Wang Y, Armaly J, Tumas V, Zabetian CP, Leverenz JB, Shi M, Zhang J. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain : a Journal of Neurology. 134: e178. PMID 21349902 DOI: 10.1093/Brain/Awr015 |
0.45 |
|
| 2011 |
Snapinn KW, Larson EB, Kawakami H, Ujike H, Borenstein AR, Izumi Y, Kaji R, Maruyama H, Mata IF, Morino H, Oda M, Tsuang DW, Yearout D, Edwards KL, Zabetian CP. The UCHL1 S18Y polymorphism and Parkinson's disease in a Japanese population. Parkinsonism & Related Disorders. 17: 473-5. PMID 21345711 DOI: 10.1016/J.Parkreldis.2011.01.019 |
0.544 |
|
| 2011 |
Leverenz JB, Watson GS, Shofer J, Zabetian CP, Zhang J, Montine TJ. Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease. Parkinsonism & Related Disorders. 17: 61-4. PMID 21044858 DOI: 10.1016/J.Parkreldis.2010.10.003 |
0.467 |
|
| 2011 |
Factor SA, Steenland NK, Higgins DS, Molho ES, Kay DM, Montimurro J, Rosen AR, Zabetian CP, Payami H. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 564-8. PMID 20884673 DOI: 10.1136/Jnnp.2010.222042 |
0.488 |
|
| 2010 |
Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, ... ... Zabetian CP, et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Archives of Neurology. 67: 1350-6. PMID 21060011 DOI: 10.1001/Archneurol.2010.279 |
0.508 |
|
| 2010 |
Bekris LM, Mata IF, Zabetian CP. The genetics of Parkinson disease. Journal of Geriatric Psychiatry and Neurology. 23: 228-42. PMID 20938043 DOI: 10.1177/0891988710383572 |
0.564 |
|
| 2010 |
Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 75: 1189-94. PMID 20876472 DOI: 10.1212/Wnl.0B013E3181F4D832 |
0.502 |
|
| 2010 |
Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2682-5. PMID 20818673 DOI: 10.1002/Mds.23287 |
0.538 |
|
| 2010 |
Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genetics. 42: 781-5. PMID 20711177 DOI: 10.1038/Ng.642 |
0.456 |
|
| 2010 |
Poorkaj P, Raskind WH, Leverenz JB, Matsushita M, Zabetian CP, Samii A, Kim S, Gazi N, Nutt JG, Wolff J, Yearout D, Greenup JL, Steinbart EJ, Bird TD. A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1409-17. PMID 20629132 DOI: 10.1002/Mds.23085 |
0.441 |
|
| 2010 |
Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neuroscience Letters. 480: 78-82. PMID 20540987 DOI: 10.1016/J.Neulet.2010.06.009 |
0.367 |
|
| 2010 |
Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, Checkoway H, Samii A, Costa LG, Griffith A, Roberts JW, Yearout D, Zabetian CP. Human PON1, a biomarker of risk of disease and exposure. Chemico-Biological Interactions. 187: 355-61. PMID 20338154 DOI: 10.1016/J.Cbi.2010.03.033 |
0.357 |
|
| 2010 |
Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain : a Journal of Neurology. 133: 713-26. PMID 20157014 DOI: 10.1093/Brain/Awq008 |
0.398 |
|
| 2010 |
Payami H, Kay DM, Zabetian CP, Schellenberg GD, Factor SA, McCulloch CC. Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease. Genetic Epidemiology. 34: 92-9. PMID 19582778 DOI: 10.1002/Gepi.20439 |
0.325 |
|
| 2010 |
Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews. 29: 79-125. PMID 19358229 DOI: 10.1002/Mas.20221 |
0.395 |
|
| 2010 |
Leverenz JB, Zabetian C, Steinbart EJ, Nickel K, Rumbaugh M, Montine TJ, Bird TD. Four siblings with variable clinical and pathological characteristics of Alzheimer's and Lewy body disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.768 |
0.362 |
|
| 2009 |
Ragland M, Hutter C, Zabetian C, Edwards K. Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis American Journal of Epidemiology. 170: 1344-1357. PMID 19864305 DOI: 10.1093/Aje/Kwp288 |
0.445 |
|
| 2009 |
Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, ... ... Zabetian CP, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine. 361: 1651-61. PMID 19846850 DOI: 10.1056/Nejmoa0901281 |
0.429 |
|
| 2009 |
Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, Montine TJ. Cognitive impairment and dementia in patients with Parkinson disease. Current Topics in Medicinal Chemistry. 9: 903-12. PMID 19754405 DOI: 10.2174/156802609789378218 |
0.545 |
|
| 2009 |
Zabetian CP, Yamamoto M, Lopez AN, Ujike H, Mata IF, Izumi Y, Kaji R, Maruyama H, Morino H, Oda M, Hutter CM, Edwards KL, Schellenberg GD, Tsuang DW, Yearout D, et al. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1034-41. PMID 19343804 DOI: 10.1002/Mds.22514 |
0.571 |
|
| 2009 |
Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, ... ... Zabetian CP, et al. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics. 10: 347-53. PMID 19308469 DOI: 10.1007/S10048-009-0187-Z |
0.521 |
|
| 2009 |
Bar-Shira A, Hutter CM, Giladi N, Zabetian CP, Orr-Urtreger A. Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. Neurogenetics. 10: 355-8. PMID 19283415 DOI: 10.1007/S10048-009-0186-0 |
0.49 |
|
| 2009 |
Mata IF, Cosentino C, Marca V, Torres L, Mazzetti P, Ortega O, Raggio V, Aljanati R, Buzó R, Yearout D, Dieguez E, Zabetian CP. LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay. Parkinsonism & Related Disorders. 15: 370-3. PMID 18980856 DOI: 10.1016/J.Parkreldis.2008.09.002 |
0.479 |
|
| 2009 |
Ross OA, Spanaki C, Griffith A, Lin CH, Kachergus J, Haugarvoll K, Latsoudis H, Plaitakis A, Ferreira JJ, Sampaio C, Bonifati V, Wu RM, Zabetian CP, Farrer MJ. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. Parkinsonism & Related Disorders. 15: 466-7. PMID 18952485 DOI: 10.1016/J.Parkreldis.2008.09.001 |
0.416 |
|
| 2009 |
Costa-Mallen P, Zabetian C, Zhang J, Samii A, Grifflth A, Roberts J, Checkoway H. P3.103 Serum iron levels are lower in Parkinson's disease patients as compared to controls and are modifled by haptoglobin phenotype Parkinsonism & Related Disorders. 15: S174. DOI: 10.1016/S1353-8020(09)70667-4 |
0.38 |
|
| 2009 |
Kay D, Montimurro J, Schlossmacher M, Bresnick E, Stevens C, Zabetian C, Factor S, Higgins D, Scherzer C, Payami H. P3.039 Polymorphisms in the transcription factor gene GATA2 and GATA-2 target region in a-synuclein (SNCA) are associated with Parkinson's disease (PD) Parkinsonism & Related Disorders. 15: S158. DOI: 10.1016/S1353-8020(09)70603-0 |
0.529 |
|
| 2009 |
Payami H, Kay D, Stevens C, Montimurro J, Hamza T, Zabetian C, Factor S, Higgins D, Moses L, Zareparsi S, Schellenberg G, Nutt J. P2.067 Resolving mode-of-inheritance and association of PRKN with PD in a comprehensive sequence and copy-number-variation (CNV) analysis of 3800 subjects Parkinsonism & Related Disorders. 15: S106-S107. DOI: 10.1016/S1353-8020(09)70418-3 |
0.429 |
|
| 2008 |
Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. The Lancet. Neurology. 7: 583-90. PMID 18539534 DOI: 10.1016/S1474-4422(08)70117-0 |
0.574 |
|
| 2008 |
Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 1222-30. PMID 18404644 DOI: 10.1002/Ajmg.B.30758 |
0.533 |
|
| 2008 |
Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, ... ... Zabetian CP, et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology. 70: 1456-60. PMID 18337586 DOI: 10.1212/01.Wnl.0000304044.22253.03 |
0.514 |
|
| 2008 |
Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC, Schellenberg GD, Sidransky E, Bird TD, Leverenz JB, Tsuang D, Zabetian CP. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Archives of Neurology. 65: 379-82. PMID 18332251 DOI: 10.1001/Archneurol.2007.68 |
0.483 |
|
| 2008 |
McCulloch CC, Kay DM, Factor SA, Samii A, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Montimurro JS, Zabetian CP, Payami H. Exploring gene-environment interactions in Parkinson's disease. Human Genetics. 123: 257-65. PMID 18210157 DOI: 10.1007/S00439-008-0466-Z |
0.483 |
|
| 2008 |
Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 134-9. PMID 18093156 DOI: 10.1111/J.1468-1331.2007.02012.X |
0.56 |
|
| 2008 |
Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 88-95. PMID 17987647 DOI: 10.1002/Mds.21782 |
0.4 |
|
| 2007 |
Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62: 137-44. PMID 17514749 DOI: 10.1002/Ana.21157 |
0.413 |
|
| 2007 |
Chun LS, Samii A, Hutter CM, Griffith A, Roberts JW, Leis BC, Mosley AD, Wander PL, Edwards KL, Payami H, Zabetian CP. DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease. Annals of Neurology. 62: 99-101. PMID 17503507 DOI: 10.1002/Ana.21149 |
0.52 |
|
| 2007 |
Leverenz JB, Yu CE, Montine TJ, Steinbart E, Bekris LM, Zabetian C, Kwong LK, Lee VM, Schellenberg GD, Bird TD. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain : a Journal of Neurology. 130: 1360-74. PMID 17439980 DOI: 10.1093/Brain/Awm069 |
0.357 |
|
| 2007 |
Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, Schellenberg GD, Payami H. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Annals of Neurology. 61: 47-54. PMID 17187375 DOI: 10.1002/Ana.21039 |
0.48 |
|
| 2006 |
Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, ... ... Zabetian CP, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. The Lancet. Neurology. 5: 917-23. PMID 17052658 DOI: 10.1016/S1474-4422(06)70579-8 |
0.386 |
|
| 2006 |
Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing. 10: 221-7. PMID 17020475 DOI: 10.1089/Gte.2006.10.221 |
0.511 |
|
| 2006 |
Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, Dürr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, et al. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Archives of Neurology. 63: 1250-4. PMID 16966502 DOI: 10.1001/Archneur.63.9.1250 |
0.504 |
|
| 2006 |
Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. American Journal of Human Genetics. 79: 752-8. PMID 16960813 DOI: 10.1086/508025 |
0.475 |
|
| 2006 |
Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. Journal of Alzheimer's Disease : Jad. 9: 293-348. PMID 16914840 DOI: 10.3233/Jad-2006-9309 |
0.49 |
|
| 2006 |
Zabetian CP, Morino H, Ujike H, Yamamoto M, Oda M, Maruyama H, Izumi Y, Kaji R, Griffith A, Leis BC, Roberts JW, Yearout D, Samii A, Kawakami H. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology. 67: 697-9. PMID 16728648 DOI: 10.1212/01.Wnl.0000227732.37801.D4 |
0.529 |
|
| 2006 |
Zabetian CP, Lauricella CJ, Tsuang DW, Leverenz JB, Schellenberg GD, Payami H. Analysis of the LRRK2 G2019S mutation in Alzheimer Disease. Archives of Neurology. 63: 156-7. PMID 16401756 DOI: 10.1001/Archneur.63.1.156 |
0.508 |
|
| 2006 |
Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 519-23. PMID 16250030 DOI: 10.1002/Mds.20751 |
0.538 |
|
| 2005 |
Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology. 65: 741-4. PMID 16157909 DOI: 10.1212/01.Wnl.0000172630.22804.73 |
0.541 |
|
| 2005 |
Kay DM, Kramer P, Higgins D, Zabetian CP, Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1077-8. PMID 16001413 DOI: 10.1002/Mds.20618 |
0.447 |
|
| Show low-probability matches. |